SCHEMBL146183

SCHEMBL146183

CC(C)NC(C)C.CCC(O)CCN

nearest known ligand 0.36

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.36
GABRR1 P24046 2/20 0.33
TSHR P16473 1/20 0.33
GABBR2 O75899 2/20 0.32
GABBR1 Q9UBS5 2/20 0.32
SPHK1 Q9NYA1 1/20 0.30
TRPV1 Q8NER1 1/20 0.30
TRPA1 O75762 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19090256 0.85
SCHEMBL22527 0.85
SCHEMBL13528424 0.85
Hydrochloric Acid SCHEMBL23174946 0.83
Silicate SCHEMBL11490053 0.74 GABRR1 (0.34) GABRR1GABBR2GABBR1
SCHEMBL11322914 0.73
Butanol SCHEMBL27620184 0.72 TSHR (0.67) TDP1TSHR
Propylamine SCHEMBL1685445 0.72 TDP1 (0.53) TDP1TSHR
Ethylamine SCHEMBL612047 0.71 TDP1 (0.61) TDP1
SCHEMBL23017495 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120058057-A1 Anti-dandruff Agents MERCK PATENT GMBH (DE) 2012-03-08 US claimed
US-20120058057-A1 Anti-dandruff Agents MERCK PATENT GMBH (DE) 2012-03-08 US disclosed
WO-2010136105-A2 AMMONIUMCARBOXYLATES MERCK PATENT GMBH (DE) 2010-12-02 WO disclosed
WO-2010136104-A2 ANTI-DANDRUFF AGENTS MERCK PATENT GMBH (DE) 2010-12-02 WO disclosed
US-20100119461-A1 ANTIMICROBIAL COMPOSITION MERCK PATENT GMBH (DE) 2010-05-13 US disclosed
EP-2112882-A2 ANTIMICROBIAL COMPOSITION COMPRISING ZINC OXIDE, BARIUM SULPHATE AND SILVER IONS Merck Patent GmbH (DE) 2009-11-04 EP disclosed
WO-2008089822-A2 ANTIMICROBIAL COMPOSITION COMPRISING ZINC OXIDE, BARIUM SULPHATE AND SILVER IONS MERCK PATENT GMBH (DE) 2008-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100119461-A1 ANTIMICROBIAL COMPOSITION ZFR, SOD1, NISCH TDP1 3272/4885GABRR1 599/4885TSHR 1791/4885
US-20120058057-A1 Anti-dandruff Agents POLR1C, ETF1, PIK3C3 TDP1 968/4885GABRR1 346/4885TSHR 4265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.